Detalles de la búsqueda
1.
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria.
Circulation
; 149(6): 450-462, 2024 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952217
2.
Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
Circulation
; 2024 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38583093
3.
Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials.
J Am Soc Nephrol
; 34(12): 1965-1975, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37876229
4.
The Effect of Weight Loss Through Lifestyle Interventions in Patients With Heart Failure With Preserved Ejection Fraction-A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Heart Lung Circ
; 33(2): 197-208, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38320881
5.
Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trials.
Kidney Int
; 104(1): 181-188, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37119876
6.
Rapid Chemical Screening of Microplastics and Nanoplastics by Thermal Desorption and Pyrolysis Mass Spectrometry with Unsupervised Fuzzy Clustering.
Anal Chem
; 95(33): 12373-12382, 2023 Aug 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37567156
7.
The importance of targeting multiple risk markers in patients with type 2 diabetes: A post-hoc study from the CANVAS programme.
Diabetes Obes Metab
; 25(6): 1638-1645, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36782264
8.
Kidney protection with canagliflozin: A combined analysis of the randomized CANVAS program and CREDENCE trials.
Diabetes Obes Metab
; 25(8): 2331-2339, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37184050
9.
The effects of canagliflozin in type 2 diabetes in subgroups defined by population-specific body mass index: Insights from the CANVAS Program and CREDENCE trial.
Diabetes Obes Metab
; 25(12): 3724-3735, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37671609
10.
Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysis.
Diabetes Obes Metab
; 24(10): 1927-1938, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35589614
11.
Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk.
Heart Fail Clin
; 18(4): 645-654, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36216493
12.
Empagliflozin in Patients with Chronic Kidney Disease.
N Engl J Med
; 388(24): 2300, 2023 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37314720
13.
The mechanism of resistance to favipiravir in influenza.
Proc Natl Acad Sci U S A
; 115(45): 11613-11618, 2018 11 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30352857
14.
Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: Insights from the CANVAS Program and CREDENCE trial.
Diabetes Obes Metab
; 26(2): 758-762, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37881140
15.
Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial.
Diabetes Obes Metab
; 25(5): 1413-1418, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36655422
16.
Knowledge, attitudes, and behaviors related to dietary salt intake and the acceptability of salt substitute among the Australian culturally and linguistically diverse community: An online survey.
J Clin Hypertens (Greenwich)
; 26(5): 543-552, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38563696
17.
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD: A Meta-Analysis of CKD Progression Trials.
Clin J Am Soc Nephrol
; 2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38622766
18.
Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials.
J Am Heart Assoc
; 12(13): e028516, 2023 07 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37345834
19.
Early risk assessment for COVID-19 patients from emergency department data using machine learning.
Sci Rep
; 11(1): 4200, 2021 02 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33603086
20.
Electrostatic microprobe for determining charge domains on surfaces.
Rev Sci Instrum
; 86(11): 113702, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26628139